BEAM - Beam Therapeutics GAAP EPS of -$1.21 beats by $0.23 revenue of $7.41M misses by $7.25M
2024-05-07 06:35:53 ET
More on Beam Therapeutics
- Beam Therapeutics: A 'Hold' Amid High Valuation And Uncertain Revenue Prospects
- Beam Therapeutics: Cool Tech, But At A Way Inflated Price For Now
- Verve drops after pausing trial enrollments for lead asset
- Beam reverses gains after mixed shelf offering
- Seeking Alpha’s Quant Rating on Beam Therapeutics